Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,135.9
7.5 (0.24%)

 

  • STI Straits Times Index
    3,135.9
    7.5 (0.24%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,602.8
    6.3 (0.39%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,231.5
    -60.3 (-0.23%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,880.0
    -3.1 (-0.11%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    20,677.2
    114.1 (0.55%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,295.7
    -1.0 (-0.02%)
    Index delayed 10 minutes
  • KOR KOSPI
    1,960.2
    20.3 (1.05%)
    Index delayed 20 minutes
  • XAO XAO
    6,627.4
    76.9 (1.17%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 791.8M
  • Value: 911.6M
  • Rise: 143
  • Fall: 158
  • Unch: 535

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
LionGold0.001-
YZJ Shipbldg SGD0.970-0.040
Rex Intl0.076-0.002
ThaiBev0.890+0.005
TEE Intl0.072-0.001
Genting Sing0.895-
SingTel3.220+0.030
ESR-REIT0.510-0.010
Ascott Reit1.300+0.020
Golden Agri-Res0.285-0.005

World Indices

World Indices
Name Last Change
Nasdaq 8,002.8 +106.8
HSI 26,231.5 -60.3
HSCEI 10,132.8 +23.6
Jakarta 6,295.7 -1.0
Nikkei 225 20,677.2 +114.1
SSE Comp 2,880.0 -3.1
Shanghai A 3,017.1 -3.2
Shanghai B 264.6 -1.3
PSE Comp 0.0
KOSPI 1,960.2 +20.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SELLAS LIFE SCIENCES GROUP INC SELLAS LIFE SCIENCES GROUP
Updated on 19 Aug 2019 (End of trading day)
Last (USD): 0.155 Change: -0.004 High: 0.158 Remarks: -
Change (%): -2.45 Low: 0.152
Open 0.153 Yesterday's Close 0.15889999999999999
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 11,720,610 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.18209 Trailing EPS (USD) e -0.14046 NAV (USD) b 0.0633
PE a - Trailing PE f - Price / NAV b 2.4487
Dividend (USD) d - Cash In Hand (USD) g 0.0568 Issued & Paid-up Shares c 226,545,000
Dividend Yield (%) d - Price / Cash In Hand g 2.729 Treasury Shares h -
Beta - 75 Daysi 0.731 R-Squared - 75 Days(%)i 0.68 Market Cap (M) 35.114
Beta - 500 Daysi -0.135 R-Squared - 500 Days (%)i 0.03 Enterprise Value (M) 22.639
Piotroski F Score 2 Exchange Code SLS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 165.73 Free Float (%) 99.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 Jan 2018.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SELLAS LIFE SCIENCES GROUP INC NASDAQ 35.114 - - 2.4487 -
Industry Biotechnology NASDAQ 2,259.618 128.991 100.049 5.2298 0.783
Local Peer AMGEN INC NASDAQ 123,538.406 14.717 15.524 11.4451 2.691
Local Peer GILEAD SCIENCES INC NASDAQ 81,192.110 14.884 13.634 3.5900 3.600
Local Peer CELGENE CORP NASDAQ 67,486.318 16.680 12.803 6.7144 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 48,088.678 22.939 21.711 9.4850 -
Local Peer BIOGEN INC NASDAQ 43,477.847 9.813 8.213 3.3566 -
Local Peer ILLUMINA INC NASDAQ 42,431.550 51.370 45.236 9.7949 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,790.276 13.414 15.846 3.3611 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 25,265.898 325.589 18.946 2.4859 -
Local Peer INCYTE CORPORATION NASDAQ 18,177.463 166.015 59.429 8.0890 -
Local Peer EXACT SCIENCES CORP NASDAQ 15,299.948 - - 19.9861 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 13,892.231 - - 4.6918 -
Local Peer SEATTLE GENETICS INC NASDAQ 13,406.034 - - 10.5408 -
Other Local Peers IONIS PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIO-TECHNE CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), REPLIGEN CORP (NASDAQ), MODERNA INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), TILRAY INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), UNIQURE N.V. (NASDAQ), NATERA INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), EPIZYME INC (NASDAQ), VERACYTE INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), OPKO HEALTH INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), INTREXON CORP (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), OMEROS CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ARVINAS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), RETROPHIN INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), MACROGENICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), CORTEXYME INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), TG THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEXTCURE INC (NASDAQ), AVROBIO INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), IMMUNOGEN INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MERUS B V (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AGENUS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), MEDICINOVA INC (NASDAQ), RESTORBIO INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), XBIOTECH INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PROTHENA CORP PLC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), GERON CORP (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), COMPUGEN (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), KAMADA (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), SERES THERAPEUTICS (NASDAQ), MANNKIND CORPORATION (NASDAQ), CHIASMA INC (NASDAQ), ATHERSYS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AFFIMED N V (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ARDELYX INC (NASDAQ), CHIMERIX INC (NASDAQ), XOMA CORP (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), IMV INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), SESEN BIO INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), TOCAGEN INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), VERASTEM INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADS EACH REPR 1 ORD SHARE (NASDAQ), AQUINOX PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), VACCINEX INC (NASDAQ), ORGENESIS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ARAVIVE INC (NASDAQ), EQUILLIUM INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), OTONOMY INC (NASDAQ), INFLARX N V (NASDAQ), VBI VACCINES INC CDA (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CURIS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), INMUNE BIO INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VERMILLION INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), IVERIC BIO INC (NASDAQ), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), EVOGENE LTD (NASDAQ), SENESTECH INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ZAFGEN INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), BIOCARDIA INC (NASDAQ), SOLIGENIX INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BIOCEPT INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), VICAL INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), HISTOGENICS CORP (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TROVAGENE INC (NASDAQ), ATYR PHARMA INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), ADVAXIS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), OPGEN INC (NASDAQ), NEURALSTEM INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ)
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CSL ASX 106,238.439 39.598 39.598 14.1970 1.143
Global Peer AGILENT TECHNOLOGIES INC NYSE 22,672.498 71.749 21.150 4.7762 0.836
Global Peer SINO BIOPHARM HKEx 126,555.646 11.811 12.124 3.6511 0.727
Global Peer WUXI BIO HKEx 103,049.480 137.968 137.968 11.3045 -
Global Peer BEIGENE HKEx 70,159.842 - - 5.7794 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer GENSCRIPT BIO HKEx 33,516.180 201.568 201.563 8.9432 -
Global Peer 3SBIO HKEx 31,835.200 21.045 21.045 3.2407 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,278.656 36.342 - 2.3042 -
Other Global Peers FRONTAGE (HKEx), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), MYOVANT SCIENCES LTD (NYSE), ASCLETIS-B (HKEx), AVITA MEDICAL LTD (ASX), MESOBLAST LTD (ASX), CKLIFE SCIENCES (HKEx), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), KADMON HLDGS INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), NEXT SCIENCE LTD (ASX), LEE'S PHARM (HKEx), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), 22ND CENTURY GROUP INC (NYSE American), PFENEX INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), ENZO BIOCHEM INC (NYSE), UNI-BIO GROUP (HKEx), PALATIN TECHNOLOGIES INC (NYSE American), BBI LIFE SCI (HKEx), STANDARD DIVERSIFIED INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), NEUREN PHARMACEUTICALS LTD (ASX), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PORT (SET), CEL-SCI CORP (NYSE American), RESAPP HEALTH LIMITED (ASX), IBIO INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), PHYLOGICA LIMITED (ASX), HEMISPHERX BIOPHARMA INC (NYSE American), IMMUTEP LTD (ASX), IMUGENE LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), REGENT PACIFIC (HKEx), ORTHOCELL LIMITED (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), ZELDA THERAPEUTICS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIOTRON (ASX), RHINOMED LIMITED (ASX), ONCOSIL MEDICAL LIMITED (ASX), BIOSINO BIO-TEC (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), EXTRAWELL PHAR (HKEx), MEMPHASYS LTD (ASX), ORAGENICS INC (NYSE American), ISORAY INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), PATRYS LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NANOVIRICIDES INC (NYSE American), ADALTA LTD (ASX), BIONOMICS LTD (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), IMMURON LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CELLMID LIMITED (ASX), Suntar Eco-City^ (SGX), PRESCIENT THERAPEUTICS LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), HOLISTA COLLTECH LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), BENITEC BIOPHARMA LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), BIOXYNE LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), MGRC (Bursa), QT Vascular (SGX), HAO WEN HLDGS (HKEx), ACTINOGEN MEDICAL LTD (ASX), MEGASUN (Bursa), CCP TECHNOLOGIES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), NANOLLOSE LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), MEDIBIO LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), BPH ENERGY LIMITED (ASX), ALCHEMIA LIMITED (ASX), GENERA BIOSYSTEMS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.005
-3.12 %
10 Days --0.017
-9.88 %
20 Days -+0.027
+21.09 %
Medium Term Return 3 Months --0.653
-80.82 %
6 Months --1.255
-89.01 %
1 Year --0.710
-82.08 %
Annualised Return Annualised --
-82.08 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.102 - 2.460 Change From 1 Year Low +0.053 % Change From 1 Year Low (%) +51.81
Change From 1 Year High -2.305 % Change From 1 Year High (%) -93.70
2 Years Range 0.102 - 11.090 Change From 2 Years Low +0.053 % Change From 2 Years Low (%) +51.81
Change From 2 Years High -10.935 % Change From 2 Years High (%) -98.60
5 Years Range 0.102 - 11.090 Change From 5 Years Low +0.053 % Change From 5 Years Low (%) +51.81
Change From 5 Years High -10.935 % Change From 5 Years High (%) -98.60
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

SELLAS Life Sciences Group, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the development and commercialization of novel cancer immunotherapeutics for cancer indications. Its product galinpepimut-S, or GPS, is an immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, which targets the Wilms tumor 1, or WT1, protein. Its products include galinpepimut-S and nelipepimut-S. The company was founded on April 3, 2006 and is headquartered in New York, NY.

Historical Price Data

Date Open High Low Close Volume VWAP
19 Aug 2019 0.153 0.158 0.152 0.155 11,720,610 -
16 Aug 2019 0.160 0.165 0.147 0.159 17,269,910 -
15 Aug 2019 0.172 0.179 0.153 0.157 39,864,140 -
14 Aug 2019 0.160 0.160 0.144 0.147 21,913,810 -
13 Aug 2019 0.160 0.165 0.151 0.160 13,210,780 -
12 Aug 2019 0.169 0.169 0.156 0.162 16,318,470 -
09 Aug 2019 0.170 0.171 0.163 0.165 12,450,620 -
08 Aug 2019 0.165 0.176 0.161 0.169 18,053,920 -
07 Aug 2019 0.174 0.174 0.155 0.168 20,624,910 -
06 Aug 2019 0.179 0.185 0.168 0.172 23,880,930 -
05 Aug 2019 0.180 0.199 0.179 0.184 44,663,320 -
02 Aug 2019 0.159 0.180 0.158 0.180 40,036,380 -
01 Aug 2019 0.160 0.183 0.156 0.157 41,158,470 -
31 Jul 2019 0.236 0.249 0.156 0.170 141,732,600 -
30 Jul 2019 0.160 0.205 0.155 0.202 91,546,170 -
29 Jul 2019 0.145 0.164 0.141 0.160 33,362,360 -
26 Jul 2019 0.153 0.179 0.145 0.158 100,033,700 -
25 Jul 2019 0.124 0.147 0.121 0.143 45,575,770 -
24 Jul 2019 0.128 0.128 0.124 0.126 13,858,720 -
23 Jul 2019 0.133 0.134 0.125 0.128 16,208,200 -
22 Jul 2019 0.130 0.133 0.123 0.131 22,244,150 -
19 Jul 2019 0.121 0.130 0.121 0.127 21,214,500 -
Summary
Current 2 Weeks
(06 Aug 2019 to 19 Aug 2019)
0.179 0.185 0.144 0.155 195,308,100 -
Previous 2 Weeks
(23 Jul 2019 to 05 Aug 2019)
0.133 0.185 0.125 0.184 568,175,690 -
4 Weeks from
(24 Jun 2019 to 22 Jul 2019)
0.144 0.185 0.131 0.131 904,300,436 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.